Open/Future Solicitations


Agency: HHS
Solicitation: RFA-HD-15-012
Open Period: 29-Jul-2014 to 29-Aug-2014
Topic: Topics Not Yet Determined RFA-HD-15-012
Topic Description: Topics will be added as determined

Agency: HHS
Solicitation: RFA-HD-15-012
Open Period: 29-Jul-2014 to 29-Aug-2014
Topic: Funding Opportunity Description
Topic Description: The purpose of this FOA is to support projects that demonstrate the presence of protein biomarkers that are related to brain structure or neurological function in patients in the chronic stages of traumatic brain injury (CBI).  The research will provide anatomical evidence for changes in… more

Agency: HHS
Solicitation: PA-11-347
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: NINDS SBIR Technology Transfer
Topic Description: The NINDS SBIR Technology Transfer (SBIR-TT) Funding Opportunity Announcement (FOA) is intended to help move commercially-viable neuroscience based technologies from the NIH Intramural Program to the marketplace.  Small Business Concerns (SBCs) are encouraged to submit applications that… more

Agency: HHS
Solicitation: PA-11-340
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: Development of novel and emerging technologies for the accurate detection and diagnosis of polymicrobial infections in biomedical laboratory animal models
Topic Description: Microbial infections in biomedical laboratory animal models have become an increasingly important topic, because the constant possibility of outbreaks that may threaten the survival or utility of biomedical animal models available for current and future research needs. This funding opportunity… more

Agency: HHS
Solicitation: PA-11-341
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: Development of Novel and Emerging Technologies for the Accurate Detection and Diagnosis of Polymicrobial Infections in Biomedical Laboratory Animal Models
Topic Description: Microbial infections in biomedical laboratory animal models have become an increasingly important topic, because the constant possibility of outbreaks that may threaten the survival or utility of biomedical animal models available for current and future research needs. This funding opportunity… more

Agency: HHS
Solicitation: PA-11-335
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: Lab to Marketplace: Tools for Biomedical and Behavioral Research
Topic Description: The NIH and other research sponsors invest a significant amount of funds in the development of new technologies to study biology and behavior, from basic and clinical perspectives, through a variety of mechanisms, including, from NIH, the R01, R21, P01, P41, and P50 grants. This investment has… more

Agency: HHS
Solicitation: PAR-11-304
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: Development of Appropriate Pediatric Formulations and Drug Delivery Systems
Topic Description: Purpose This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups.… more

Agency: HHS
Solicitation: PAR-11-305
Open Period: 05-Nov-2011 to 08-Sep-2014
Topic: Development of Appropriate Pediatric Formulations and Drug Delivery Systems
Topic Description: Purpose This Funding Opportunity Announcement (FOA) invites Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups.… more

Agency: HHS
Solicitation: RFA-AT-15-003
Open Period: 10-Aug-2014 to 10-Sep-2014
Topic: Topics Not Yet Determined RFA-AT-15-003
Topic Description: Topics will be added as determined

Agency: HHS
Solicitation: RFA-AT-15-003
Open Period: 10-Aug-2014 to 10-Sep-2014
Topic: Funding Opportunity Description
Topic Description: Background Natural products are essential sources of medicines.  The World Health Organization estimates that ~80% of the world’s population relies on traditional medicines made from natural products. The modern pharmaceutical industry is also dependent on plant-based medicines, with as… more